Case ID: 606052
Solution ID: 12

Genentech Capacity Planning Case Solution


While aiding a complicated clinical approval process over the following two to three years for just about any number of new cancer drugs, Genentech must produce a extended-term capacity request a substantial kind of new cancer products. Adding towards the complexness and uncertainty is the fact charge here i am at planning, building, and validating a completely new $600 million plus production-scale facility is five years. Furthermore, making sure the very best process technology is built-into this kind of new plant helps to make the task facing David Ebersman, the senior vice-leader of products methods, and also the management team a frightening one. Frames the issues Ebersman and also the team face and outlines the approach thus far.

Request Case Study Solution

Prepared by MBAs and CFAs according to your requirements



Already Registered? Login here!


Order Summary

SubjectNot Selected
LengthNot Selected
Deadline Not Selected
Estimated Submission On
Total 0